Table 1.
Characteristics of participants included (n = 22).
| Subject characteristics | Healthy participants Mean (SD) | Hemodialysis group Mean (SD) |
|---|---|---|
| Age (years) | 50.8 (14.0) | 50.6 (15.7) |
| Weight (kg) | 75.27 (13.24) | 75.1 (26.3) |
| Height (cm) | 168.1 (8.6) | 167.3 (12.7) |
| BMI (kg/m2) | 26.3 (3.3) | 26.68 (7.7) |
| Charlson Comorbidity Index | 0.16 (0.72) | 4.2 (2.4) |
| HAP‐MAS | 87.8 (5.3) | 69.3 (16.5) |
| HAP‐AAS | 85.4 (8.3) | 57.8 (16.7) |
| Number of medications | 1 (1.33) | 11.4 (2.4) |
| Cause of ESRD | Glomerulonephritis – 6 Polycystic Kidney Disease‐5 Hypertensive nephropathy‐4 Other nephropathies‐3 IgA nephropathy‐1 Vasculitis‐1 Rhabdomyolysis‐1 ESRD‐NYD‐1 |
AAS, adjusted activity score; BMI, body mass index; ESRD, end‐stage renal disease; HAP, human activity profile; NYD, not yet diagnosed; SD, standard deviation.